Основные параметры
P/S |
58.42 |
P/BV |
29.27 |
EV/EBITDA |
-110.38 |
EBITDA |
-0.0554 |
Цена ао |
248.45 |
Все параметры ⇨
Оценка
|
Недооценка
Название |
Значение |
Оценка |
P/S |
58.42 |
1 |
P/BV |
29.27 |
1 |
P/E |
|
0 |
EV/EBITDA |
-110.38 |
10 |
|
|
|
|
Эффективность
Название |
Значение |
Оценка |
ROA, % |
-15.19 |
1 |
ROE, % |
-30.96 |
1 |
|
|
|
|
|
Дивиденды
Название |
Значение |
Оценка |
Div yield, % |
|
0 |
DSI |
0 |
0 |
|
|
|
|
Долг
Название |
Значение |
Оценка |
Долг/EBITDA |
|
0 |
|
|
|
|
Импульс роста
Название |
Значение |
Оценка |
Рост прибыли, % |
13.79 |
3 |
Рост цены акции, % |
0 |
0 |
Рост дивидендов, % |
0 |
0 |
|
|
|
|
Содержится в ETF
Похожие компании
Описание Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was founded in 2007 and is headquartered in Golden Valley, Minnesota.